Tenax Therapeutics Inc (TENX)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current TENX market cap is 11.62M. The company's latest EPS is USD -2.2620 and P/E is -1.51.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.24M | -2.12M | -3.34M | -3.91M | -3.67M |
| Net Income | -1.11M | -1.97M | -3.23M | -3.8M | -3.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.56M | -9.87M | -32.73M | -11.05M | -8.23M |
| Net Income | -8.39M | -9.85M | -32.47M | -11.05M | -7.71M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 14.05M | 11.89M | 11.69M | 14.46M | 10.62M |
| Total Liabilities | 823k | 602k | 3.59M | 2.03M | 1.74M |
| Total Equity | 13.22M | 11.29M | 8.1M | 12.43M | 8.88M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 6.37M | 50M | 5.99M | 3.41M | 11.69M |
| Total Liabilities | 2.59M | 0 | 1.75M | 1.91M | 3.59M |
| Total Equity | 3.77M | 50M | 4.25M | 1.49M | 8.1M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -2.65M | -4.73M | -5.9M | -5.17M | -8.2M |
| Investing | 3k | 3k | 3k | N/A | N/A |
| Financing | 13.92M | 13.74M | 13.57M | 7.92M | 7.79M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.56M | -9.27M | -10.86M | -12.01M | -5.9M |
| Investing | -2k | 20k | 452k | -2k | 3k |
| Financing | 97k | 10.6M | 9.74M | 8.56M | 13.57M |
| Market Cap | 11.62M |
| Price to Earnings Ratio | -1.51 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.19 |
| Price to Book Ratio | 1.44 |
| Dividend Yield | - |
| Shares Outstanding | 3.41M |
| Average Volume (1 week) | 29.82k |
| Average Volume (1 Month) | 28.64k |
| 52 Week Change | -84.78% |
| 52 Week High | 61.152 |
| 52 Week Low | 2.77 |
| Spread (Intraday) | 0.43 (11.17%) |
| Company Name | Tenax Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.tenaxthera.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
